The CDSCO has approved a new indication for Wegovy (semaglutide injection 2.4 mg) for treatment of noncirrhotic metabolic ...

Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug Wegovy ​for the ...

A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging ...

MEXICO: TANZANIA is pursuing a comprehensive strategy to tackle malnutrition while addressing the growing burden of ...

Novo Nordisk's Wegovy receives CDSCO approval as India's first GLP-1 treatment for fatty liver disease, addressing rising ...

Researchers develop a new way of assessing a person’s risk of heart failure or death, by using AI during chest scans to measure the size of the pectoral muscle ...

Doctors are warning that popular GLP-1 medications used for diabetes and weight loss, including drugs such as Ozempic and ...

Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic ...

A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International ...

Researchers have developed a targeted fibrosis screening strategy that reduces the number of adults flagged for testing, ...

GLP-1 drugs can help diabetes and obesity, but in ALS, weight loss may speed decline. New reports suggest doctors should be ...

Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic ...